Predicting Drug–Drug Interactions Between Rifampicin and Long-Acting Cabotegravir and Rilpivirine Using Physiologically Based Pharmacokinetic Modeling
Author:
Affiliation:
1. Department of Molecular and Clinical Pharmacology, University of Liverpool, United Kingdom
2. Johns Hopkins University School of Medicine and Bloomberg School of Public Health, Baltimore, Maryland
Funder
National Institutes of Health
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Immunology and Allergy
Link
http://academic.oup.com/jid/article-pdf/219/11/1735/28560108/jiy726.pdf
Reference43 articles.
1. World Health Organization. Global tuberculosis report.http://www.who.int/tb/publications/global_report/en/ . Accessed 1 August 2018.
2. Joint United Nations Programme on HIV/AIDS. Fact sheet.http://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf. Accessed 1 February 2018.
3. Risk and prognostic significance of tuberculosis in patients from the TREAT Asia HIV observational database;Zhou;BMC Infect Dis,2009
4. Outcome of tuberculosis treatment in HIV-positive adults diagnosed through active versus passive case-finding;Balcha;Glob Health Action,2015
5. An updated systematic review and meta-analysis on the treatment of active tuberculosis in patients with HIV infection;Ahmad Khan;Clin Infect Dis,2012
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical pharmacology considerations and drug–drug interactions with long‐acting cabotegravir and rilpivirine relevant to sub‐Saharan Africa;British Journal of Clinical Pharmacology;2024-06-25
2. Physiologically based Pharmacokinetic Model Validated to Enable Predictions Of Multiple Drugs in a Long-acting Drug-combination Nano-Particles (DcNP): Confirmation with 3 HIV Drugs, Lopinavir, Ritonavir, and Tenofovir in DcNP Products;Journal of Pharmaceutical Sciences;2024-06
3. Two-drug regimens for the treatment of HIV in Africa;The Lancet HIV;2024-06
4. Clinical considerations and pharmacokinetic interactions between HIV and tuberculosis therapeutics;Expert Review of Clinical Pharmacology;2024-02-14
5. Physiologically‐based pharmacokinetic modelling of long‐acting injectable cabotegravir and rilpivirine in pregnancy;British Journal of Clinical Pharmacology;2024-02-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3